[{"Assets_0_Q2_USD":151968000.0,"CommonStockSharesOutstanding_0_Q2_shares":54747656.0,"NetIncomeLoss_1_Q2_USD":-20318000.0,"NetIncomeLoss_2_Q2_USD":-45605000.0,"StockholdersEquity_0_Q2_USD":140527000.0,"Ticker":"DVAX","CIK":"1029142","name":"DYNAVAX TECHNOLOGIES CORP","OfficialName":"Dynavax Technologies Corporation Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1279198792.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170807"}]